Health Dictionary Find a Doctor

Allergic conjunctivitis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]

Overview

Overview

Allergic conjunctivitis is usually a non-progressive condition with a favorable prognosis, and rare but serious complications. Most symptoms are self-limiting, while in some subtypes, a temporal association can be found with the age group and specific triggers. Complications include infections, scarring and can also damage the cornea and eyelids. Long-term prognosis is influenced by the recurrence of the attacks and side-effects of treatment.

Natural History

Natural History

Symptoms are often neglected, and resolve in many patients without medical care.

Complete resolution without the return of symptoms after adolescence is observed in a majority of patients.

Uncommon before adolescence and peaks from 30 to 50 years of age. Most cases coexist with atopic dermatitis.

  • A temporal relationship with contact lens use may explain the predominance of this variety in teens and young adults.
  • It manifests usually after one to two years of wearing soft contact lenses but varies widely with other ocular foreign bodies[1].
Complications

Complications

In most cases, allergic conjunctivitis is a benign condition. Complications although rare,can be serious and include:

Prognosis[2]

Prognosis[2]

  • PAC and SAC demonstrate favorable long-term outcomes but, significant eye discomfort and poor ocular cosmesis may persist as long-term sequelae in many people.
  • Recurrences result in conjunctivochalasis, which is a result of ongoing limba conjunctival chemosis.
  • The medications may cause adverse reactions like cataracts.
References

References

  1. Sen E, Celik S, Inanc M, Elgin U, Ozyurt B, Yılmazbas P (2018). “Seasonal distribution of ocular conditions treated at the emergency room: a 1-year prospective study”. Arq Bras Oftalmol. 81 (2): 116–119. doi:10.5935/0004-2749.20180026. PMID 29846426.
  2. 2.0 2.1 2.2 Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H; et al. (2017). “Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis”. Allergy. 72 (11): 1597–1631. doi:10.1111/all.13201. PMID 28493631.

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH